Gastroenterology
Volume 129, Issue 3 , Pages 827-836, September 2005

The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study

  • Charles N. Bernstein

      Affiliations

    • Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Manitoba, Canada
    • Section of Gastroenterology, Department of Internal Medicine, University of Manitoba, Manitoba, Canada
    • Corresponding Author InformationAddress requests for reprints to: Charles N. Bernstein, MD, University of Manitoba, 804F-715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E-3P4. fax: (204) 789-3972.
  • ,
  • Andre Wajda

      Affiliations

    • Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Manitoba, Canada
  • ,
  • James F. Blanchard

      Affiliations

    • Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Manitoba, Canada
    • Department of Community Health Sciences, Winnipeg, Manitoba, Canada

Received 26 January 2005; accepted 26 May 2005.

Background & Aims: We aimed to discern the relative risk for several chronic inflammatory conditions in patients with ulcerative colitis (UC) and Crohn’s disease. Methods: We used the population-based University of Manitoba IBD Database that includes longitudinal files on all patients from all health system contacts identified by International Classification of Diseases, 9th revision, Clinical Modification codes for visit diagnosis. From the provincial database we extracted a control cohort matching the IBD patients 10:1 by age, sex, and geography. We considered a potential comorbid disease to be present if the patient had 5 or more health system contacts for that diagnosis. The comorbid disease period prevalence was analyzed separately for patients with UC and Crohn’s disease and a prevalence ratio was calculated comparing the IBD populations with the matched cohort. Results: There were 8072 cases of IBD from 1984 to 2003, including UC (n = 3879) and Crohn’s disease (n = 4193). There was a mean of approximately 16 person-years of coverage for both patients and control patients. Both UC and Crohn’s disease patients had a significantly greater likelihood of having arthritis, asthma, bronchitis, psoriasis, and pericarditis than population controls. An increased risk for chronic renal disease and multiple sclerosis was noted in UC but not Crohn’s disease patients. The most common nonintestinal comorbidities identified were arthritis and asthma. Conclusions: The finding of asthma as the most common comorbidity increased in Crohn’s disease patients compared with the general population is novel. These may be diseases with common causes or complications of one disease that lead to the presentation with another. Studies such as this should encourage further research into the common triggers in the organ systems that lead to autoimmune diseases.

Abbreviations used in this paper:  CI, confidence interval , ICD-9-CM, International Classification of Diseases, 9th revision, Clinical Modification , OR, odds ratio , PR, prevalence ratio

 

 Supported in part by a Canadian Institutes of Health Research Investigator Award and by a Crohn’s and Colitis Foundation of Canada Research Scientist Award (to C.N.B.).

PII: S0016-5085(05)01123-6

doi:10.1053/j.gastro.2005.06.021

Refers to article:

  • Inflammatory Bowel Disease Extending Its Reach

    Edward V. Loftus
    Gastroenterology September 2005 (Vol. 129, Issue 3, Pages 1117-1120)

Gastroenterology
Volume 129, Issue 3 , Pages 827-836, September 2005